prognosis.

November 16, 2016November 16, 2016

Lymphoma DNA in Blood Offers Easy Access to Treatment, Relapse, Prognosis Insights

News

Bits of cancer DNA circulating in the blood of lymphoma patients can provide physicians with information on the cancer subtype and identify mutations linked to treatment resistance. The findings bring ... Read more

October 6, 2016

New Prognosis Prediction Tool Suggested for Lymphoma, but Experts Call for More Evaluation

News

Measuring total metabolic tumor volume may improve the accuracy of prognosis prediction in follicular lymphoma patients, according to a study analyzing data from several clinical trials. But experts caution that the method ... Read more

September 27, 2016September 27, 2016

Factors Identify Likely Outcomes in Lymphoma Patients on Third-Line Treatment

News

Researchers identified prognostic factors in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who underwent autologous stem cell transplants before relapsing again — taking on, in this work, rarely ... Read more

August 10, 2016September 12, 2016

What You Need to Know About Non-Hodgkin Lymphoma

In 2015, findings from a study showed that doing intense physical activity throughout one’s lifetime could lower the risk of non-Hodgkin lymphoma (NHL). With this video by Cancer GPS, listen as Dr. Bayard L. Powell, of Wake ... Read more

July 13, 2016July 13, 2016

Prognosis of Primary Gastric Lymphomas May Be Predicted with Double-Protein, Study Finds

News

Attempting to identify molecular markers of primary gastric B-cell lymphoma, researchers in China found that so-called double-hit lymphoma is rare in these patients, while a double-protein appearance of tumors predicts ... Read more

June 10, 2016June 10, 2016

Poor Prognosis of Chemotherapy-Resistant Lymphoma Underscores Urgent Need for New Therapies

News

California-based Kite Pharma recently announced results from a large analysis of outcomes from chemorefractory diffuse large B-cell lymphoma, showing that these chemotherapy-resistant patients typically have a poor prognosis, irrespective of disease ... Read more

February 11, 2016February 11, 2016

Follicular Lymphoma Patients Can Safely Use Statins During Rituximab Treatment, Study Reports

News

Although statin use has been poorly associated with rituximab in laboratory experiments, a study investigating the concomitant use of statins and rituximab in follicular lymphoma patients has concluded that statin use is safe and ... Read more

February 10, 2016March 2, 2016

Non-Hodgkin Lymphoma – What You Need to Know

In this video by Cancer GPS, watch “world-renowned specialist Bayard L. Powell, M.D., of Wake Forest Baptist Health discuss non-Hodgkin’s lymphoma and the risk factors, diagnosis, staging, treatment and prognosis.” ... Read more